Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||
| DOI | 10.1016/J.JBC.2025.108387 | ||
| Año | 2025 | ||
| Tipo |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Atrial fibrillation (AF) involves electrical remodeling of the atria, with ion channels such as NaV1.5, KV1.5, and TASK-1 playing crucial roles. This study investigates acetamide-based compounds designed as multi-target inhibitors of these ion channels to address AF. Compound 6f emerged as the most potent in the series, demonstrating a strong inhibition of TASK-1 (IC50 ∼ 0.3 μM), a moderate inhibition of NaV1.5 (IC50 ∼ 21.2 μM) and a subtle inhibition of KV1.5 (IC50 ∼ 81.5 μM), alongside unexpected activation of TASK-4 (∼ 40% at 100 μM). Functional assays on human atrial cardiomyocytes from sinus rhythm (SR) and patients with AF revealed that 6f reduced action potential amplitude in SR (indicating NaV1.5 block), while in AF it increased action potential duration (APD), reflecting high affinity for TASK-1. Additionally, 6f caused hyperpolarization of the resting membrane potential in AF cardiomyocytes, consistent with the observed TASK-4 activation. Mathematical modeling further validated its efficacy in reducing AF burden. Pharmacokinetic analyses suggest favorable absorption and low toxicity. These findings identify 6f as a promising multi-target therapeutic candidate for AF management.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Camargo-Ayala, Lorena | - |
Universidad de Talca - Chile
|
| 2 | Bedoya, Mauricio | - |
Universidad Católica del Maule - Chile
|
| 3 | Dasí, Albert | - |
University of Oxford - Reino Unido
|
| 4 | Prüser, Merten | - |
Universität Heidelberg - Alemania
|
| 5 | Schütte, Sven | - |
Philipps-Universität Marburg - Alemania
|
| 6 | Prent-Peñaloza, Luis | - |
Universidad Nacional Andrés Bello - Chile
|
| 7 | Adasme-Carreño, Francisco | - |
Universidad Católica del Maule - Chile
|
| 8 | Kiper, Aytug K. | - |
Philipps-Universität Marburg - Alemania
Universitätsmedizin Greifswald - Alemania |
| 9 | Rinne, Susanne | Mujer |
Philipps-Universität Marburg - Alemania
|
| 10 | Camargo-Ayala, Paola Andrea | - |
Universidad de Talca - Chile
|
| 11 | Peña-Martínez, Paula A. | - |
Universidad de Talca - Chile
|
| 12 | Bueno-Orovio, Alfonso | - |
University of Oxford - Reino Unido
|
| 13 | Varela, Diego | - |
Núcleo Milenio de Enfermedades asociadas a Canales Iónicos - Chile
Universidad de Chile - Chile |
| 14 | Wiedmann, Felix | - |
Universität Heidelberg - Alemania
|
| 15 | Márquez Montesinos, José C.E. | - |
Universidad de Talca - Chile
|
| 16 | Mazola, Yuliet | - |
Universidad de Talca - Chile
|
| 17 | Venturini, Whitney | - |
Universidad Católica del Maule - Chile
|
| 18 | ZUNIGA-HORMAZABAL, RAFAEL ENRIQUE | Hombre |
Universidad de Talca - Chile
|
| 19 | ZUNIGA-HORMAZABAL, LEANDRO ANTONIO | Hombre |
Universidad de Talca - Chile
|
| 20 | Schmidt, Constanze | - |
Universität Heidelberg - Alemania
|
| 21 | Rodriguez, Blanca | - |
University of Oxford - Reino Unido
|
| 22 | Ravens, Ursula | - |
German Atrial Fibrillation Competence NETwork (AFNET) - Alemania
Universitäts Herzzentrum Freiburg Bad Krozingen - Alemania |
| 23 | Decher, Niels | Hombre |
Philipps-Universität Marburg - Alemania
|
| 24 | GUTIERREZ-GARCIA, MARIA GLORIA | Mujer |
Universidad de Talca - Chile
|
| 25 | González, Wendy | - |
Núcleo Milenio de Enfermedades asociadas a Canales Iónicos - Chile
Universidad de Talca - Chile |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Universidad de Talca |
| Deutsche Forschungsgemeinschaft |
| Wellcome Trust |
| Engineering and Physical Sciences Research Council |
| Else Kroner-Fresenius-Stiftung |
| German Foundation of Heart Research |
| Deutsches Zentrum für Herz-Kreislaufforschung |
| Fondecyt-ANID |
| Deutsche Herzstiftung |
| CBSM |
| Basic Biomedical Sciences |
| Center for Bioinformatics, Simulation and Modelling |
| Philipps University |
| Agradecimiento |
|---|
| During the preparation of this work, the author(s) used ChatGPT (OpenAI, 2022) in order to proofread and enhance the grammatical accuracy of the manuscript. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication. W. G. conceptualization; L. C-A. M. B. A. D. M. P. S. S. Y. M. W. V. R. Z. L. Z. C. S. B. R. U. R. N. D. M. G. and W. G. data curation; L. C-A. M. B. A. D. M. P. L. P-P. F. A-C. A. K. K. S. R. P. A. C-A. P. A. P-M. A. B.-O. D. V. F. W. and J. C. E. M-M. formal analysis; M. G. W. G. L. C-A. M. B. P. P-M. P. A. C-A. L. Z. C. S. and F. W. funding acquisition; L. C-A. M. B. A. D. M. P. L. P-P. F. A-C. P. A. C-A. F. W. and J. C. E. M-M. investigation; L. C-A. M. B. A. D. M. P. F. A-C. A. K. K. S. R. P. A. C-A. F. W. S. S. Y. M. W. V. R. Z. L. Z. C. S. B. R. N. D. M. G. and W. G. methodology; W. G. project administration; L. Z. C. S. B. R. N. D. M. G. and W. G. resources; M. B. F. A-C. A. D. A. B-O. and B. R. software; R. Z. L. Z. C. S. B. R. U. R. N. D. M. G. and W. G. supervision; L. C-A. M. B. A. D. M. P. L. P-P. F. A-C. A. K. K. S. R. P. A. C-A. P. A. P-M. A. B-O. D. V. F. W. J. C. E. M-M. S. S. Y. M. W. V. R. Z. L. Z. C. S. B. R. U. R. N. D. M. G. and W. G. validation; L. C-A. M. B. A. D. M. P. A. K. K. P. A. C-A. P. A. P-M. F. W. and J. C. E. M-M. visualization; L. C-A. M. B. A. D. M. P. and F. W. writing\u2013original draft; L. C-A. M. B. A. D. M. P. L. P-P. A. K. K. S. R. D. V. C. S. B. R. U. R. N. D. M. G. and W. G writing\u2013review & editing. The authors acknowledge the Research Group of the Laboratory of Organic Synthesis and Biological Activity, Laboratory of Electrophysiology of the Institute of Physiology and Pathophysiology, Philipps University. Marburg, Germany and the Center for Bioinformatics, Simulation and Modelling (CBSM) of the University of Talca, Fondecyt Projects 1200531, 1230446 and 1230996 and FIC-R Gore Maule project 40.027.577-0. L. C-A. acknowledges the ANID National Doctorate Scholarship 2019 Folio N\u00B0 21190020. M. B. acknowledges FONDECYT-ANID for his postdoctoral grant N\u00B0 3210774. P. P-M. acknowledges the ANID National Doctorate Scholarship 2019 Folio N\u00B0 21190245. PA. C-A. acknowledges the ANID National Doctorate Scholarship 2021 Folio N\u00B0 21220448. CS was funded in part by research grants from the German Heart Foundation/German Foundation of Heart Research (F/03/19, Atrial fibrillation grant), the Else-Kr\u00F6ner Fresenius Foundation (EKFS Clinician-Scientist professorship), the German Centre for Cardiovascular Research (DZHK TRP grant, innovation cluster grant, shared expertise). C. S. ad F. W. are members of the CRC1425 and CRC1550, funded by the German Research Foundation (#422681845 and #464424253). B. R. acknowledges funding from the EPSRC Impact Acceleration Account (UKRI Grant Reference - EP/X525777/1) and Wellcome Trust Senior Fellowship in Basic Biomedical Sciences (214290/Z/18/Z). W. V. acknowledges Fondecyt-ANID Iniciacion 11251459. |
| The authors acknowledge the Research Group of the Laboratory of Organic Synthesis and Biological Activity, Laboratory of Electrophysiology of the Institute of Physiology and Pathophysiology, Philipps University. Marburg, Germany and the Center for Bioinformatics, Simulation and Modelling (CBSM) of the University of Talca, Fondecyt Projects 1200531, 1230446 and 1230996 and FIC-R Gore Maule project 40.027.577-0. L.C-A. acknowledges the ANID National Doctorate Scholarship 2019 Folio N\u00B0 21190020. M.B. acknowledges FONDECYT-ANID for his postdoctoral grant N\u00BA 3210774. P.P-M. acknowledges the ANID National Doctorate Scholarship 2019 Folio N\u00B0 21190245. PA.C-A. acknowledges the ANID National Doctorate Scholarship 2021 Folio N\u00B0 21220448. CS was funded in part by research grants from the German Heart Foundation /German Foundation of Heart Research (F/03/19, Atrial fibrillation grant), the Else-Kr\u00F6ner Fresenius Foundation (EKFS Clinician-Scientist professorship), the German Centre for Cardiovascular Research (DZHK TRP grant, innovation cluster grant, shared expertise). CS ad FW are members of the CRC1425 and CRC1550, funded by the German Research Foundation (#422681845 and #464424253). |